Connecticut ranks high in opioid-related visits to hospitals
With opioids in wide circulation, Dr. Gail D’Onofrio, chief of emergency medicine at the hospital and chairwoman of emergency medicine at Yale School of Medicine, isn’t sure that one-day spike will stand as a record.Source: New Haven Register
Patients with opioid addiction benefit from treatment initiated in ED
Patients addicted to opioids often seek care in the emergency department (ED). They are more likely to receive addiction treatment, and reduce opioid use long-term if they are started on medication to reduce cravings in the ED, according to a new Yale study.
Emergency department treatment for opioid addiction better than referrals
Yale researchers conducted the first known randomized trial comparing three treatment strategies for opioid-dependent patients receiving emergency care. They found that patients given the medication buprenorphine were more likely to engage in addiction treatment and reduce their illicit opioid use.
Yale doc says addiction should be on physicians’ minds
Philip Seymour Hoffman dies with a syringe in his arm and addiction is back in the news. That shouldn’t be the case, according to Dr. Patrick G. O’Connor, new president of the American Board of Addiction Medicine, who believes every doctor should have addiction in mind when treating patients.Source: New Haven Register
Five-minute intervention can help patients with substance and behavioral problems
A brief 5 to 10 minute intervention in an emergency department can provide effective help to patients with substance and behavioral problems, and should be broadly implemented, say the authors of a new Yale study. Their recommendations appear in the December issue of Health Affairs.
$15M NIDA Grant Awarded to Serena Spudich, Mark Gerstein, and Yuval Kluger
Principal Investigators Serena Spudich, MD, MA (Neurology), Mark Gerstein, PhD (Molecular Biophysics and Biochemistry), and Yuval Kluger, PhD (Pathology) were recently awarded a $15 million grant from the National Institute on Drug Abuse (NIDA) to establish a Data Center to coordinate, analyze, and make accessible single-cell and other molecular data sets generated by Single-Cell Opioid Responses in the Context of HIV (SCORCH) and other NIDA-funded HIV and substance use disorder projects.